WAKANSE (1783) March 2026 Revenue: 70 Million Yen (Year-on-Year +0.1%)
WAKANSE announced its revenue for March 2026, reaching 69.939 million yen (approximately 0.70 hundred million yen), a slight increase of 0.1% compared to the same period last year. The company operates in the biotechnology and healthcare industry.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: April 12, 2026 at 16:30 (1015h 30m after Published)
- 🤖 AI Analyzed: April 12, 2026 at 17:27 (57 min after Collected)
Company Code: 1783
Company Name: WAKANSE
Industry: Biotechnology and Healthcare
Data Month: 2026-03
Monthly Revenue: 69,939 thousand yen (0.70 hundred million yen)
Year-on-Year Change (Same Month Last Year): +0.1%
Company Name: WAKANSE
Industry: Biotechnology and Healthcare
Data Month: 2026-03
Monthly Revenue: 69,939 thousand yen (0.70 hundred million yen)
Year-on-Year Change (Same Month Last Year): +0.1%
FAQ
What was WAKANSE's revenue for March 2026?
WAKANSE's monthly revenue for March 2026 was approximately 70 million yen (69.939 million yen).
How did the revenue compare to the same month last year?
It increased by 0.1% compared to the same month last year.
What kind of business does WAKANSE operate?
WAKANSE operates in the biotechnology and healthcare industry, developing and selling pharmaceuticals and medical devices.